GlassScriptPhysician profile
Emily Mathiesen
NPI 1053636092
$3,319.50
in general payments reported to CMS, 2019-2025
29 companies · $1,362 in 2025
The $1,362 reported for 2025 was more than what 91% of providers received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $352 · 2020: $80.07 · 2021: $136 · 2022: $686 · 2023: $602 · 2024: $101 · 2025: $1,362.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,564 · Travel and Lodging: $501.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,563.77 |
| Travel and Lodging | $501.26 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $1,162.88 | 2025 | |
| Abbvie INC. | $530.83 | 2019-2023 | |
| Sumitomo Pharma America, INC. | $255.62 | 2023-2025 | Myfembree |
| Myovant Sciences INC. | $174.71 | 2022 | |
| Pfizer INC. | $153.92 | 2022-2024 | |
| Daiichi Sankyo INC. | $152.48 | 2019-2023 | Injectafer |
| Biogen, INC. | $103.17 | 2025 | Zurzuvae |
| Therapeuticsmd, INC. | $94.77 | 2019-2022 | |
| Coopersurgical, INC. | $84.09 | 2022-2023 | Paragard T 380a |
| Myriad Women'S Health, INC. | $76.21 | 2023 | Myrisk |
| Medtronic, INC. | $64.57 | 2022-2023 | Truclear |
| Hologic Sales and Service, LLC | $63.86 | 2019-2024 | Thinprep 2000 Processor, Aptima, Third Wave |
| Mayne Pharma Commercial LLC | $57.84 | 2022-2023 | |
| Organon LLC | $42.70 | 2023-2025 | Jada System, Nexplanon |
| Astellas Pharma US INC | $34.49 | 2023 | Veozah |
Show all 29 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Applied Medical Resources Corporation | $33.87 | 2023 | |
| Getinge USA Sales, LLC | $28.94 | 2025 | Ultima Activator II Drive Mechanism |
| Scynexis, INC. | $25.54 | 2022 | |
| Pharmacosmos Therapeutics INC. | $23.75 | 2023 | Monoferric |
| Mission Pharmacal Company | $20.08 | 2020 | |
| Minerva Surgical, INC | $17.88 | 2022 | |
| Exeltis, USA INC. | $17.39 | 2025 | Slynd |
| Covidien LP | $16.32 | 2019 | |
| Aesculap, INC. | $15.93 | 2019 | |
| Agile Therapeutics, INC. | $14.96 | 2022 | |
| Amag Pharmaceuticals, INC. | $14.65 | 2019 | |
| Pacira Pharmaceuticals Incorporated | $13.21 | 2019 | |
| Evofem Biosciences, INC. | $12.85 | 2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $11.99 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Emily Mathiesen listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.